Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
ASX Health Stocks: Neuroscientific says EmtinB shows positive signs, expects full results in H2
Escrow Watch
Escrow Watch: Which companies have shares coming out of escrow in April?
Health & Biotech
ASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slides into Greece
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Health & Biotech
ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
ASX Health Stocks: Chimeric gets licence for CAR-T from U-Pen, Acrux gets nod from the FDA
Health & Biotech
ASX health stocks: Proteomics jumps 10% on blood test deal with Nasdaq-listed Abcam
IPO Watch
IPO Watch: Which sector has provided the best performing IPOs in 2021?
Health & Biotech
Dr Boreham’s Crucible: Can Island Pharmaceuticals build the ultimate mozzie-zapper?
IPO Watch
IPO Watch: 3 IPOs have sparked the week, but health and tech stocks still outperform
News
Rise and Shine: What you need to know before the ASX opens
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
Last Orders: ASX finishes slightly in the green; tech gains 2 per cent & another IPO more than doubles
News
ASX Small Cap Lunch Wrap: Tech continues its winning ways
IPO Watch